xml_file stringlengths 5 11 | reference_id stringlengths 1 7 | date_last_updated stringclasses 487
values | pubmed_id stringlengths 5 8 ⌀ | article_year int64 1.95k 2.03k ⌀ | article_title stringlengths 23 347 ⌀ | journal_title stringlengths 3 197 ⌀ | authors stringlengths 5 2.35k ⌀ | epitope_id stringlengths 1 7 ⌀ | epitope_name stringlengths 1 85 ⌀ | epitope_structure_type stringclasses 8
values | epitope_chemical_type stringclasses 18
values | linear_sequence stringlengths 1 829 ⌀ | linear_sequence_length int64 1 829 ⌀ | discontinuous_residues stringlengths 2 419 ⌀ | starting_position int64 0 34.8k ⌀ | ending_position int64 3 34.8k ⌀ | source_organism_id stringlengths 1 8 ⌀ | source_molecule_genbank_id stringlengths 4 14 ⌀ | reference_region stringlengths 2 409 ⌀ | epitope_structure_defines stringclasses 4
values | epitope_evidence_code stringclasses 6
values | assay_category stringclasses 4
values | assay_id stringlengths 2 8 | assay_type_id stringclasses 412
values | assay_location_of_data stringlengths 4 126 ⌀ | qualitative_measurement stringclasses 5
values | is_positive bool 2
classes | quantitative_measurement stringlengths 3 25 ⌀ | host_organism_id stringclasses 729
values | host_sex stringclasses 2
values | host_age stringlengths 1 39 ⌀ | disease_state stringclasses 666
values | mhc_allele_id stringclasses 868
values | mhc_allele_types_present stringlengths 1 150 ⌀ | cell_type stringclasses 41
values | cell_tissue_type stringclasses 49
values | cell_culture_conditions stringclasses 9
values | antigen_evidence_code stringclasses 6
values | immunogen_evidence_code stringclasses 6
values | assay_comments stringclasses 0
values | split_bucket int64 1 9 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536170 | 316 | Extended Data Figure 4 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536166 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536167 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536169 | 316 | Figure 2 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454214 | Epitope of Fab COV2-3891 on Omicron BQ.1.1 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N434, K435, V440, R493, P494, T495, Y496, G497, V498, Q501 | null | null | 10002869 | WCI16184.1 | N439, K440, V445, R498, P499, T500, Y501, G502, V503, Q506 | Partial Epitope | null | BCell | 28536172 | 190 | Extended Data Figure 5 and Supplementary Table 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 8 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536147 | 436 | Figure 5, Supplementary Table 6, and PDB 9C6Y | Positive | true | 2.68 | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536173 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536174 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536175 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536176 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536177 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536178 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536179 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536180 | 316 | Figure 3 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536198 | 316 | Figure 3 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536181 | 316 | Figure 3 | Positive-Low | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536187 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536182 | 316 | Figure 3 | Positive-Low | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536183 | 316 | Figure 3 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536184 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536185 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536186 | 316 | Figure 3, Extended Data Figure 3, and Extended Data Table 1 | Positive-Intermediate | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536189 | 316 | Extended Data Figure 4 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536196 | 34 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536190 | 190 | Extended Data Figure 5 and Supplementary Table 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2454213 | Epitope of Fab COV2-3906 on Omicron XBB.1.5 RBD | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | D360, S362, Y365, N366, A368, P369, F370, F371, A372, F373, K374, C375, S379, P380, T381, N384, I430, P523, K524 | null | null | 10002975 | WBW01504.1 | D364, S366, Y369, N370, A372, P373, F374, F375, A376, F377, K378, C379, S383, P384, T385, N388, I434, P527, K528 | Exact Epitope | null | BCell | 28536197 | 316 | Figure 3 | Positive-Low | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 6 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2238037 | Epitope of mAb LY-CoV1404 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R346, N439, N440, S443, K444, V445, G446, G447, N450, Q498, P499, T500, N501, G502, Q506 | null | null | 10002321 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536233 | 308 | Figure 6 | Positive | true | null | 9606 | M | 33 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2238037 | Epitope of mAb LY-CoV1404 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R346, N439, N440, S443, K444, V445, G446, G447, N450, Q498, P499, T500, N501, G502, Q506 | null | null | 10002321 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536224 | 308 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2238037 | Epitope of mAb LY-CoV1404 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R346, N439, N440, S443, K444, V445, G446, G447, N450, Q498, P499, T500, N501, G502, Q506 | null | null | 10002321 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536234 | 308 | Figure 6 | Positive | true | null | 9606 | M | 38 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2238037 | Epitope of mAb LY-CoV1404 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R346, N439, N440, S443, K444, V445, G446, G447, N450, Q498, P499, T500, N501, G502, Q506 | null | null | 10002321 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536219 | 34 | Figure 3 | Positive | true | null | 9606 | null | 35 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2238037 | Epitope of mAb LY-CoV1404 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | R346, N439, N440, S443, K444, V445, G446, G447, N450, Q498, P499, T500, N501, G502, Q506 | null | null | 10002321 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536220 | 34 | Figures 3 and 6 | Positive | true | null | 9606 | null | 35 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 1864102 | Epitope of mAb S309 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N331, L332, P334, D336, E337, N340, A341, T342, R343, K353, S356, C358, L438, R506 | null | null | 10002533 | UJK14488.1 | null | Exact Epitope | null | BCell | 28536235 | 34 | Figure 3 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 1864102 | Epitope of mAb S309 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N331, L332, P334, D336, E337, N340, A341, T342, R343, K353, S356, C358, L438, R506 | null | null | 10002533 | UJK14488.1 | null | Exact Epitope | null | BCell | 28536236 | 34 | Figures 3 and 6 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 1864102 | Epitope of mAb S309 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N331, L332, P334, D336, E337, N340, A341, T342, R343, K353, S356, C358, L438, R506 | null | null | 10002533 | UJK14488.1 | null | Exact Epitope | null | BCell | 28536237 | 308 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 1864102 | Epitope of mAb S309 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N331, L332, P334, D336, E337, N340, A341, T342, R343, K353, S356, C358, L438, R506 | null | null | 10002533 | UJK14488.1 | null | Exact Epitope | null | BCell | 28536241 | 308 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 1864102 | Epitope of mAb S309 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N331, L332, P334, D336, E337, N340, A341, T342, R343, K353, S356, C358, L438, R506 | null | null | 10002533 | UJK14488.1 | null | Exact Epitope | null | BCell | 28536243 | 308 | Figure 6 | Positive | true | null | 9606 | M | 38 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 1864102 | Epitope of mAb S309 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N331, L332, P334, D336, E337, N340, A341, T342, R343, K353, S356, C358, L438, R506 | null | null | 10002533 | UJK14488.1 | null | Exact Epitope | null | BCell | 28536242 | 308 | Figure 6 | Positive | true | null | 9606 | M | 33 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 9 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2253649 | Epitope of mAb CR3022 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, D428, T430, L517 | null | null | 2697049 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536244 | 34 | Figure 3 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2253649 | Epitope of mAb CR3022 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, D428, T430, L517 | null | null | 2697049 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536245 | 34 | Figures 3 and 6 | Positive | true | null | 9606 | null | null | DOID:2945 | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2253649 | Epitope of mAb CR3022 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, D428, T430, L517 | null | null | 2697049 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536246 | 308 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Exact match to reference information | Representative selection | null | 3 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2253649 | Epitope of mAb CR3022 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, D428, T430, L517 | null | null | 2697049 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536247 | 308 | Figure 3 | Positive | true | null | 9606 | F | 28 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048177.xml | 1048177 | 2026-04-03-07:00 | 41820555 | 2,026 | Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants. | Nature microbiology | Seth J Zost; Naveenchandra Suryadevara; Lauren E Williamson; Suzanne M Scheaffer; Elad Binshtein; Cameron D Buchman; Nicole V Johnson; Nicholas J Catanzaro; Silvia Ravera; Nathaniel S Chapman; Luke Myers; Ajit R Ramamohan; Laura S Handal; Doan C Nguyen; Andrew Trivette; James R Martinez; Eduardo Villalobos; Stacey A Ru... | 2253649 | Epitope of mAb CR3022 | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | Y369, N370, F374, S375, T376, F377, K378, C379, Y380, G381, V382, S383, P384, T385, K386, L390, F392, D428, T430, L517 | null | null | 2697049 | P0DTC2.1 | null | Exact Epitope | null | BCell | 28536248 | 308 | Figure 6 | Positive | true | null | 9606 | M | 33 years | DOID:0080600 | null | null | null | null | null | Representative selection | Representative selection | null | 3 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536611 | 45 | Figures 3, 4 and S12 | Positive | true | 6.83 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536563 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536564 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536565 | 316 | Figure 1 and S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536475 | 437 | Figures 3, S11, Table S1 and PDB 9KWY | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536609 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536608 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536610 | 34 | Figure 3 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536612 | 45 | Figures 3, 4 and S12 | Positive | true | 7.24 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536613 | 316 | Figure 3 and S10 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537044 | 45 | Figures 2, 4, S8 and S12 | Positive-Low | true | 1480.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537045 | 262 | Figure 4 and S12 | Positive-Low | true | 84000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537046 | 263 | Figure 4 and S12 | Positive-Low | true | 0.124 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537050 | 263 | Figures 3, 4 and S12 | Positive | true | 0.000528 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537047 | 262 | Figures 3, 4 and S12 | Positive | true | 165000.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537048 | 263 | Figures 3, 4 and S12 | Positive | true | 0.0012 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537049 | 262 | Figures 3, 4 and S12 | Positive | true | 77200.0 | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537055 | 190 | Figure 6 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537051 | 602 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537052 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536492 | 45 | Figure S1 | Positive | true | 0.913 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28537054 | 600 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536487 | 45 | Figure S1 and S5 | Positive | true | 0.488 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536489 | 45 | Figure S1 | Positive | true | 0.637 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536527 | 45 | Figure S1 | Positive | true | 2.17 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536494 | 45 | Figure S1 | Positive | true | 0.438 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536495 | 45 | Figure S1 | Positive | true | 4.89 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536526 | 45 | Figure S1 | Positive | true | 4.38 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536528 | 45 | Figure S1 | Positive | true | 6.47 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536529 | 45 | Figure S1 | Positive-Low | true | 8750.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536429 | 437 | Figures 1, S11, Table S1 and PDB 9W14 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536537 | 262 | Figure S1 | Positive | true | 48400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536538 | 263 | Figure S1 | Positive | true | 0.0000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536539 | 262 | Figure S1 | Positive | true | 60400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536543 | 262 | Figure S1 | Positive | true | 195000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536540 | 263 | Figure S1 | Positive | true | 0.0000385 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536541 | 262 | Figure S1 | Positive | true | 356000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536542 | 263 | Figure S1 | Positive | true | 0.0000325 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536544 | 263 | Figure S1 | Positive | true | 0.0000855 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536545 | 262 | Figure S1 | Positive | true | 48100.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536546 | 263 | Figure S1 | Positive | true | 0.000236 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536547 | 262 | Figure S1 | Positive | true | 204000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536548 | 263 | Figure S1 | Positive | true | 0.000891 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536549 | 262 | Figure S1 | Positive | true | 217000.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536553 | 437 | Figures 2, S7, Table S1 and PDB 9KVK | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536550 | 263 | Figure S1 | Positive | true | 0.000472 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536551 | 262 | Figure S1 | Positive | true | 70400.0 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536552 | 263 | Figure S1 | Positive | true | 0.000455 | 10090 | null | null | null | null | null | null | null | null | Exact match to reference information | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536554 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536555 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536556 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536557 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536558 | 316 | Figures 1, 3, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536562 | 316 | Figure S2 | Positive-Low | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536559 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536560 | 316 | Figure 1 and S2 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454901 | Epitope of Fab 1C4 on SARS-CoV-2 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | null | null | 2697049 | P0DTC2.1 | N343, A344, T345, R346, N440, L441, S443, K444, V445, N450, P499, T500 | Partial Epitope | null | BCell | 28536561 | 316 | Figures 1, 4, S2 and S13 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 7 |
1048183.xml | 1048183 | 2026-04-21-07:00 | 41359663 | 2,025 | Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion. | PLoS pathogens | Hui Sun; Yanan Jiang; Miaolin Lan; Ming Zhou; Gangshun Yi; Juan Shen; Tingting Deng; Liqin Liu; Yang Huang; Yu Li; Jinfu Su; Yanling Lin; Zhenqin Chen; Lizhi Zhou; Tingting Li; Hai Yu; Tong Cheng; Yali Zhang; Lunzhi Yuan; Shaowei Li; Ying Gu; Peijun Zhang; Ningshao Xia; Qingbing Zheng | 2454905 | Epitope of Fab 1C4 on SARS-CoV-2 BA.5 S | DiscontinuousRegionOnAccessionSequenceMolecule | Discontinuous protein residues | null | null | E335, N338, A339, T340, R341, K435, L436, S438, V440, N445, T495 | null | null | 10003192 | UUB67338.1 | E340, N343, A344, T345, R346, K440, L441, S443, V445, N450, T500 | Partial Epitope | null | BCell | 28537445 | 602 | Figure 5 | Positive | true | null | 10090 | null | null | null | null | null | null | null | null | Representative selection | Representative selection | null | 1 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.